Massachusetts 2023-2024 Regular Session

Massachusetts Senate Bill S3012

Caption

Relative to pharmaceutical access, costs and transparency

Companion Bills

No companion bills found.

Previously Filed As

MA SB190

Providing for pharmaceutical transparency; establishing the Pharmaceutical Transparency Review Board and providing for its powers and duties; establishing the Pharmaceutical Transparency Review Fund; and imposing a penalty.

MA S895

To promote transparency and prevent price gouging of pharmaceutical drug prices

MA HB07179

An Act Concerning Pharmaceutical Marketing And Pharmaceuticals.

MA S868

Enhancing health care market oversight and pharmaceutical access

MA HB918

Provides relative to pharmaceutical costs (OR +$153,127 GF EX See Note)

MA SB0003

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

MA SB2104

PHARMACEUTICALS-SOCIAL MEDIA

MA HB4544

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

MA SB3046

PHARMACEUTICALS-SOCIAL MEDIA

MA HB4638

Relating to the Texas Pharmaceutical Initiative.

Similar Bills

NJ A538

"Pharmaceutical Representative Licensing Act."

VA HB1989

Medical cannabis program; changes requirements for product labels, dispensing cannabis products.

VA HB391

Medical cannabis program; product labels, delivery, marijuana delivery operators.

VA HB391

An Act to amend and reenact §§ 4.1-1600, 4.1-1602, and 4.1-1603 of the Code of Virginia, relating to medical cannabis program; product labels; delivery.

AR HB1301

To Amend The Prior Authorization Transparency Act.

NJ S2894

Establishes New Jersey Active Pharmaceutical Ingredient Regulatory Commission.

CT SB01355

An Act Concerning Prescription Drugs, Devices And Nonlegend Drugs.

KY SB2

AN ACT relating to correctional facilities.